Sugammadex Sodium Patent Expiration
Sugammadex Sodium is Used for reversing drug-induced neuromuscular blockage. It was first introduced by Merck Sharp And Dohme Llc A Sub Of Merck And Co Inc
Sugammadex Sodium Patents
Given below is the list of patents protecting Sugammadex Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Bridion |
USRE44733 (Pediatric) | 6-mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block | Jul 27, 2026 | Msd Sub Merck |
| Bridion | USRE44733 | 6-mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block | Jan 27, 2026 | Msd Sub Merck |
| Bridion | US6949527 | 6-Mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
Jan 27, 2021
(Expired) | Msd Sub Merck |
| Bridion | US7265009 | HDP-CVD methodology for forming PMD layer |
Aug 07, 2020
(Expired) | Msd Sub Merck |
| Bridion | US7265099 | Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
Aug 07, 2020
(Expired) | Msd Sub Merck |
Sugammadex Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List